Non-invasive vibratory neuromodulation for the treatment of headache and other neurological disorders

An overview of the neuromodulation landscape

James Cavuoto is editor and publisher of Neurotech Business Report and the founder of Neurotech Reports. He is the lead author of “The Market for Neurotechnology,” and “The Market for Bioelectronic Medicine,” two market research reports published by Neurotech Reports. Cavuoto was the founder of Micro Publishing Press, Inc., a publishing company that helped pioneer the market for electronic publishing, digital imaging, and computer graphics. He earned a B.S. degree in biomedical engineering from Case Western Reserve University, where he studied under pioneers in the field of functional electrical stimulation. He also pursued graduate studies in human factors engineering at University of Southern California. Cavuoto spent three years as a member of the technical staff at Hughes Aircraft Company in Los Angeles, where he worked on simulation, training, and publication products produced for the U.S. Department of Defense. Cavuoto was an adjunct professor at Rochester Institute of Technology and the author of eight books on computer graphics, electronic publishing, and digital imaging. He is a member of the IEEE Engineering in Medicine and Biology Society. He has authored a chapter in the textbook Neuromodulation (Elsevier, 2009), as well as articles in Neuromodulation, Journal of Neural Engineering, Medical Device Daily, IEEE Spectrum, MX magazine, and the International Journal of Medical Marketing. He is coauthor, with Jennifer French, of Bionic Pioneers: Brave Neurotech Users Blaze the Trail to New Therapies (Neurotech Press, 2014).

An overview of trillen medical, a novel noninvasive neuromodulation device

Jeremy Koff is a seasoned medical device commercialization expert with 25 years’ experience in assisting companies from inception through IPO/acquisition.   He has worked for or consulted to 20 neuromodulation companies throughout his career.  He has helped companies to achieve combined exits of nearly $10 billion USD.   He has served as a board member and/or advisor to numerous organizations.  In late 2021 he formed Trillen Medical Corporation based on intellectual property acquired through a licensing agreement with UCLA to commercialize a clinical-stage non-invasive neuromodulation device targeting select neurological disorders.  He is a passionate musician (cello/piano) and an avid mountain biker, skier and swimmer.  He resides in Studio City, CA with his 4-year old daughter.